Summary: Telavancin is a lipoglycopeptide antimicrobial agent under development for use in the treatment of multidrug-resistant gram-positive infections. Telavancin, like vancomycin, inhibits cell ...

[14] The addition of the lipophilic decylaminoethyl substituent to the molecule classifies this agent as a lipoglycopeptide. RYAN J. ATTWOOD, PHARM.D., is Postgraduate Year 1 Pharmacy Resident ...